Regeneron Pharmaceuticals

Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others

placeTarrytown, New York, United States calendar_todayFounded 1988 groups13,450 employees language regeneron.com

Registered entities

Investor mix

9 investors on record.

Investor typeCountShare
Venture capital333%
Private equity444%
Other / undisclosed222%

Hiring activity

Hires frequently

108 roles tracked across 8 of the last 12 months

29 May 2026 · Senior Manager, Product Management - Delivery & Operations Product Lead · Warren

27 May 2026 · Senior Manager, Product Manager - Delivery & Operations Product Lead – Enabling Technologies · Warren

15 May 2026 · Associate Director Statistical Programming - Pharmacometrics · Warren

11 May 2026 · Medical Specialist II-Ophthalmology-Denver · Denver

9 May 2026 · Assoc Director Medical Communications - Switzerland · Basel

Based on job postings tracked across public sources.

Coming soon